Skip to main content
Caplight Logo









Syrebo

Syrebo

Private
ShanghaiHealthcare & Life Scienceshttps://www.syrebo.com/

Last Round

Series A

Mar 6, 2023

Total Funding Raised

$15M

Company Overview

Syrebo is a medical technology company that develops and manufactures rehabilitation robots for clinical and home use.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Health IoT, D2C Brands

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Application

Keywords

rehabilitation roboticssoft robotic glovestroke rehabilitationlimb exoskeletonBrain-Computer InterfaceBCIwearable roboticsrehab techexoskeleton suithome rehabilitationmedical AIassistive technologysoft exoskeletonneurorehabilitationD2C medical devicesAI gait algorithm

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Syrebo Comparables

Compare Syrebo with similar companies based on industry and business-model similarity.

Syrebo comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Roceso Technologies
92%
Bioliberty
85%
Zunosaki Limited
84%

Syrebo Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 6, 2023
Pre SeedAug 9, 2021
VC RoundApr 1, 2021

Key People

Founding team and executive leadership

Gavin yin

Chief Executive Officer

Executive Team

Syrebo Investors

Notable investors and investment history

Syrebo investors
InvestorRounds
Daoyuan CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 9, 2025

    Monthly visitors increased 95% MoM.

  • Oct 29, 2025

    Attending Singapore Week of Innovation & Technology (SWITCH) Oct 29-31, 2025.

Recent news

Latest coverage and updates

  • attends_eventAug 31, 2026

    Syrebo attended event REHACARE 2026 on Aug 31st '26.

  • attends_eventJul 27, 2026

    Syrebo plans to attend event KHF 2026 on Aug 19th '26.

Syrebo Filings

Explore SEC and related filing metadata, where available.

Syrebo filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Syrebo's valuation, stock price, and market status.

Is Syrebo a public or private company?

Syrebo is a private company.

What is the current stock price of Syrebo?

Syrebo is a private company with no public stock price. No recent secondary market data is available.

How much is Syrebo worth (valuation)?

Valuation information for Syrebo is not publicly available.

Can I buy Syrebo stock?

Syrebo shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Syrebo's last funding round?

Syrebo's most recent funding round was Series A on March 6, 2023.

Who are the main investors in Syrebo?

Investor information for Syrebo is not publicly disclosed.

Will Syrebo IPO soon?

No public IPO plans have been announced for Syrebo.

How can I track Syrebo secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Syrebo's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersShanghai
Employee Range10
Year Founded2017
Last FundingMar 6, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?